Healthcare Knuggets
Jan 30, 2026 Subject: How one overdose antidote went bust Summary: A promising overdose antidote, Opvee, initially hailed as more effective than Narcan, failed due to lack of acceptance among users who experienced severe withdrawal symptoms, coupled with a New York Attorney General investigation into the company’s sales practices, leading
